Saturday’s Midday Movers: Dynavax (DVAX), Zynga (ZNGA), Vipshop (VIPS), Inovio Pharmaceuticals (INO), Apache (APA)

So far Saturday, May 30, NASDAQ is up 4.47% and the S&P is up 1.87%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Dynavax (DVAXResearch Report), Zynga (ZNGAResearch Report), Vipshop (VIPSResearch Report), Inovio Pharmaceuticals (INOResearch Report) and Apache (APAResearch Report).

Dynavax is up 18.6% in midday trading to $6.12. Shares opened today at $5.16. The company has a 52-week low of $1.80 and a 52-week high of $7.20. On the Street’s front, the average 12-month analyst price target for the stock is $16.00, marking a 210.08% potential upside from current levels. In a report issued on May 19, William Blair analyst Matt Phipps maintained a Buy rating on DVAX. In the last 30 days, insiders purchased $5M worth of DVAX shares. Over the last 3 months, the insider sentiment on Dynavax has been positive based on 23 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Zynga is up 11.59% in midday trading to $9.15. Shares opened today at $8.20. The company has a 52-week low of $5.51 and a 52-week high of $9.19. On the Street’s front, the average 12-month analyst price target for the stock is $8.32, marking a 1.46% potential upside from current levels. In a report issued on May 7, Credit Suisse analyst Stephen Ju maintained a Sell rating on ZNGA, with a price target of $6.00, which implies a downside of 27% from current levels. Separately, on the same day, Morgan Stanley’s Brian Nowak maintained a Buy rating on the stock and has a price target of $8.25. In the last 30 days, insiders have sold $74.75K worth of ZNGA shares and purchased $498.3K worth of ZNGA shares.

Vipshop is up 9.75% in midday trading to $17.34. Shares opened today at $15.80. The company has a 52-week low of $6.17 and a 52-week high of $18.95. On the Street’s front, the average 12-month analyst price target for the stock is $19.33, marking a 22.34% potential upside from current levels. In a report issued on May 28, Citigroup analyst Alicia Yap maintained a Buy rating on VIPS, with a price target of $23.00, which implies an upside of 46% from current levels. Separately, on March 9, UBS’s Jerry Liu maintained a Sell rating on the stock and has a price target of $15.00.

See today’s analyst top recommended stocks >>

Inovio Pharmaceuticals is up 8.86% in midday trading to $14.75. Shares opened today at $13.55. The company has a 52-week low of $1.92 and a 52-week high of $19.36. On the Street’s front, the average 12-month analyst price target for the stock is $16.57, marking a 22.29% potential upside from current levels. In a report issued on May 21, The Benchmark Company analyst Aydin Huseynov initiated coverage with a Buy rating on INO and a price target of $28.00, which represents a potential upside of 107% from where the stock is currently trading. Separately, on May 20, Roth Capital’s Jonathan Aschoff maintained a Hold rating on the stock . In the last 30 days, insiders have sold $139.6K worth of INO shares. Over the last 3 months, the insider sentiment on Inovio Pharmaceuticals has been negative based on 25 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Apache is down -7.7% in midday trading to $10.79. Shares opened today at $11.69. The company has a 52-week low of $3.80 and a 52-week high of $33.77. On the Street’s front, the average 12-month analyst price target for the stock is $10.42, marking a -10.86% potential downside from current levels. In a report issued on May 19, Morgan Stanley analyst Devin McDermott maintained a Hold rating on APA, with a price target of $10.00, which represents a potential downside of 14% from where the stock is currently trading. Separately, on March 20, MKM Partners’ John Gerdes upgraded the stock to Buy . Over the last 3 months, the insider sentiment on Apache has been positive based on 66 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.